Latest news with #MinimallyInvasive
Associated Press
9 hours ago
- Business
- Associated Press
Veras Health Names Dr. Kamal Morar as New Chief Medical Officer
CLEVELAND--(BUSINESS WIRE)--Jun 27, 2025-- Veras Health today announced the appointment of Dr. Kamal Morar, M.D., MBA as its new Chief Medical Officer. As founder and owner of Dayton Interventional Radiology, Dr. Morar brings extensive and relevant industry, operational and clinical leadership to the Veras team. 'Veras Health has long recognized the need for a Chief Medical Officer to support our physician customers and partners, and we are elated to have Dr. Morar join our executive team,' said Phil Pease, CEO of Veras Health. 'His background and entrepreneurial spirit are a perfect fit for our company's culture and his substantial clinical expertise and business acumen will help drive growth and innovation.' 'I am thrilled to join Veras Health as Chief Medical Officer,' said Dr. Morar. 'Veras has quickly become a leader in the rapidly expanding field of outpatient endovascular therapies. As the demand for minimally invasive, image-guided treatments continues to surge, the company is at the forefront, delivering proven management platforms and operational expertise tailored to outpatient settings.' Dr. Morar's focus will be on developing and scaling Interventional Radiology, Endovascular Cardiology, and Vascular Surgery services within office-based labs and ambulatory surgical centers. These advanced therapies are increasingly sought after by patients and providers alike for their safety, efficiency, and patient comfort. 'I am eager to work alongside the accomplished Veras Health executive team to meet the growing market need, elevate the standard of care, and drive the expansion of outpatient endovascular services across the nation,' he adds. About Veras Health Veras Health develops and manages Office-based Labs (OBLs), Ambulatory Surgery Centers, and Hybrid facilities built around the needs of physicians that perform minimally invasive procedures using imaging guidance to treat patients without the need for surgical intervention. View source version on CONTACT: Phil Pease [email protected] 407-590-0930 KEYWORD: UNITED STATES NORTH AMERICA OHIO INDUSTRY KEYWORD: HOSPITALS HEALTH SURGERY PRACTICE MANAGEMENT SOURCE: Veras Health Copyright Business Wire 2025. PUB: 06/27/2025 12:05 PM/DISC: 06/27/2025 12:05 PM
Yahoo
17-04-2025
- Health
- Yahoo
New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery
Studies show robotic-assisted procedures enable increased access to minimally invasive care SUNNYVALE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), today announced the publication of two studies showing how the availability of RAS helps enable access to high-quality care, improve patient outcomes, particularly in medical deserts, and contributes to the overall growth of minimally invasive care ultimately benefitting patients. The studies, published in the Journal of the Society of Laparoscopic & Robotic Surgeons and Annals of Surgery Open, are part of broader research underway by Intuitive to evaluate the availability and impact of RAS. As a leader in minimally invasive care, Intuitive is committed to identifying gaps in patient access and collaborating with healthcare providers to help them expand access and measure outcomes through evidence generation. Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery? The first study, titled 'Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery?' identified regions where patients lack access to high-quality MIS due to factors such as training availability, location, and/or hospital infrastructure. The study also examined how RAS can enable more widespread and efficient adoption of minimally invasive care. 'Minimally invasive surgery offers profound benefits for patients, from shorter recovery times to reduced postoperative complications, yet too many patients lack access due to barriers like surgeon training or hospital location,' said Intuitive's Chief Medical Officer Myriam Curet, M.D. 'This paper underscores the need for innovative solutions to give hospitals and surgeons more options to improve patient care and outcomes.' Key findings from this article, authored by a multidisciplinary team including Intuitive, include: Defining MIS Deserts: A medical desert is an area where patients lack access to health services. There are multiple barriers to MIS access, and patients in these areas may undergo open surgery more often, missing out on the benefits of MIS. Identifying Barriers to MIS Access: Surgeon characteristics, including training, board certification, years of practice, and procedure volume, accounted for nearly two-thirds of variation in MIS use for colectomy. Patient sociodemographic characteristics accounted for nearly 30 percent, and hospital characteristics, such as rural or urban location, academic status, and procedure volume accounted for about 7 percent. Impact of Robotic-Assisted Surgery: Addressing surgeon training could result in significant improvement in MIS use. RAS offers surgeons a shorter learning curve compared to traditional laparoscopy, allowing clinicians to become proficient more quickly. Telementoring and remote surgical support could further extend the reach of experienced surgeons into underserved areas. Rates of Minimally Invasive Surgery after Introduction of Robotic-Assisted Surgery for Common General Surgery Operations Building on the previous study, 'Rates of Minimally Invasive Surgery after Introduction of Robotic-Assisted Surgery for Common General Surgery Operations,' examined how the introduction of RAS has influenced rates of MIS in hospitals across the United States. The study also evaluated whether adopting RAS helped expand access to MIS across different demographics, including age, sex, race, ethnicity, and insurance status. The study evaluated data from 408 U.S. hospitals between 2016 and 2022, focusing specifically on 153 hospitals that introduced RAS for common general surgeries such as cholecystectomy, hernia repair, and colorectal resection. The findings highlight the broader impact of RAS adoption on minimally invasive surgery rates: Higher MIS Adoption: Hospitals that implemented RAS saw MIS rates increase from 60.5% to 65.8%, a significantly greater rise than hospitals that did not introduce RAS (56.1% to 57.0%). Expanded Access Across Patient Populations: Patients aged 35 and older and those with Medicare or commercial insurance saw significant MIS rate increases, suggesting a broader reach of minimally invasive techniques. Consistent Gains Across Procedures: The greatest MIS gains in RAS hospitals were seen in hernia repairs and colorectal resections, where rates outpaced those in non-RAS hospitals. Prior studies have debated whether the rise of RAS primarily shifts procedures from laparoscopy rather than expanding MIS access. This research adds to the body of evidence suggesting that, in many hospitals, the introduction of RAS contributes to overall MIS growth across populations rather than redistributing surgical methods by overcoming some of the barriers associated with laparoscopy, including ergonomic limitations and 2D visualization. 'These findings suggest that the introduction of robotic-assisted surgery is helping to expand patient access to minimally invasive techniques,' said Zhi Ven Fong, MD, MPH, DrPH, co-author, hepatobiliary and pancreas surgeon, and surgical oncologist, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic Arizona. 'By removing some of the technical challenges of traditional laparoscopy, RAS has the potential to make minimally invasive surgery a more viable option for a broader range of patients.' To date, more than 16 million patients have benefitted from minimally invasive care performed with Intuitive technologies including urology, gynecology, colorectal, general surgery, thoracic, and cardiac surgery procedures and has helped improve patient outcomes, ranging from shorter recovery times to reduced postoperative complications, depending on the procedure and individual patient characteristics. For more information about Intuitive's efforts to help advance greater access to care and specifically robotic-assisted surgery, visit References: Mitzman, Brian et al. 'Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery?.' JSLS : Journal of the Society of Laparoendoscopic Surgeons vol. 28,3 (2024): e2024.00039. doi:10.4293/JSLS.2024.00039 Fong, Zhi Ven et al. 'Rates of Minimally Invasive Surgery After Introduction of Robotic-Assisted Surgery for Common General Surgery Operations.' Annals of surgery open : perspectives of surgical history, education, and clinical approaches vol. 6,1 e546. 31 Jan. 2025, doi:10.1097/AS9.0000000000000546 Contact: Megan Elliott, About IntuitiveIntuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most. About da Vinci Surgical SystemsThere are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. For more information, please visit the company's website at Important Safety InformationFor product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, visit For summary of the risks associated with surgery refer to in to access your portfolio
Globe and Mail
17-04-2025
- Health
- Globe and Mail
New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery
SUNNYVALE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), today announced the publication of two studies showing how the availability of RAS helps enable access to high-quality care, improve patient outcomes, particularly in medical deserts, and contributes to the overall growth of minimally invasive care ultimately benefitting patients. The studies, published in the Journal of the Society of Laparoscopic & Robotic Surgeons and Annals of Surgery Open, are part of broader research underway by Intuitive to evaluate the availability and impact of RAS. As a leader in minimally invasive care, Intuitive is committed to identifying gaps in patient access and collaborating with healthcare providers to help them expand access and measure outcomes through evidence generation. Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery? The first study, titled 'Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery?' identified regions where patients lack access to high-quality MIS due to factors such as training availability, location, and/or hospital infrastructure. The study also examined how RAS can enable more widespread and efficient adoption of minimally invasive care. 'Minimally invasive surgery offers profound benefits for patients, from shorter recovery times to reduced postoperative complications, yet too many patients lack access due to barriers like surgeon training or hospital location,' said Intuitive's Chief Medical Officer Myriam Curet, M.D. 'This paper underscores the need for innovative solutions to give hospitals and surgeons more options to improve patient care and outcomes.' Key findings from this article, authored by a multidisciplinary team including Intuitive, include: Defining MIS Deserts: A medical desert is an area where patients lack access to health services. There are multiple barriers to MIS access, and patients in these areas may undergo open surgery more often, missing out on the benefits of MIS. Identifying Barriers to MIS Access: Surgeon characteristics, including training, board certification, years of practice, and procedure volume, accounted for nearly two-thirds of variation in MIS use for colectomy. Patient sociodemographic characteristics accounted for nearly 30 percent, and hospital characteristics, such as rural or urban location, academic status, and procedure volume accounted for about 7 percent. Impact of Robotic-Assisted Surgery: Addressing surgeon training could result in significant improvement in MIS use. RAS offers surgeons a shorter learning curve compared to traditional laparoscopy, allowing clinicians to become proficient more quickly. Telementoring and remote surgical support could further extend the reach of experienced surgeons into underserved areas. Rates of Minimally Invasive Surgery after Introduction of Robotic-Assisted Surgery for Common General Surgery Operations Building on the previous study, 'Rates of Minimally Invasive Surgery after Introduction of Robotic-Assisted Surgery for Common General Surgery Operations,' examined how the introduction of RAS has influenced rates of MIS in hospitals across the United States. The study also evaluated whether adopting RAS helped expand access to MIS across different demographics, including age, sex, race, ethnicity, and insurance status. The study evaluated data from 408 U.S. hospitals between 2016 and 2022, focusing specifically on 153 hospitals that introduced RAS for common general surgeries such as cholecystectomy, hernia repair, and colorectal resection. The findings highlight the broader impact of RAS adoption on minimally invasive surgery rates: Higher MIS Adoption: Hospitals that implemented RAS saw MIS rates increase from 60.5% to 65.8%, a significantly greater rise than hospitals that did not introduce RAS (56.1% to 57.0%). Expanded Access Across Patient Populations: Patients aged 35 and older and those with Medicare or commercial insurance saw significant MIS rate increases, suggesting a broader reach of minimally invasive techniques. Consistent Gains Across Procedures: The greatest MIS gains in RAS hospitals were seen in hernia repairs and colorectal resections, where rates outpaced those in non-RAS hospitals. Prior studies have debated whether the rise of RAS primarily shifts procedures from laparoscopy rather than expanding MIS access. This research adds to the body of evidence suggesting that, in many hospitals, the introduction of RAS contributes to overall MIS growth across populations rather than redistributing surgical methods by overcoming some of the barriers associated with laparoscopy, including ergonomic limitations and 2D visualization. 'These findings suggest that the introduction of robotic-assisted surgery is helping to expand patient access to minimally invasive techniques,' said Zhi Ven Fong, MD, MPH, DrPH, co-author, hepatobiliary and pancreas surgeon, and surgical oncologist, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic Arizona. 'By removing some of the technical challenges of traditional laparoscopy, RAS has the potential to make minimally invasive surgery a more viable option for a broader range of patients.' To date, more than 16 million patients have benefitted from minimally invasive care performed with Intuitive technologies including urology, gynecology, colorectal, general surgery, thoracic, and cardiac surgery procedures and has helped improve patient outcomes, ranging from shorter recovery times to reduced postoperative complications, depending on the procedure and individual patient characteristics. For more information about Intuitive's efforts to help advance greater access to care and specifically robotic-assisted surgery, visit References: Mitzman, Brian et al. 'Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery?.' JSLS : Journal of the Society of Laparoendoscopic Surgeons vol. 28,3 (2024): e2024.00039. doi:10.4293/JSLS.2024.00039 Fong, Zhi Ven et al. 'Rates of Minimally Invasive Surgery After Introduction of Robotic-Assisted Surgery for Common General Surgery Operations.' Annals of surgery open : perspectives of surgical history, education, and clinical approaches vol. 6,1 e546. 31 Jan. 2025, doi:10.1097/AS9.0000000000000546 Contact: Megan Elliott, Intuitive 1-669-222-9899 About Intuitive Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most. About da Vinci Surgical Systems There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body. For more information, please visit the company's website at
Yahoo
03-04-2025
- Business
- Yahoo
Vascular Closure Device Market Size Projected to Grow to USD 3.03 Billion by 2030, Fuelled by Cardiovascular Disease Prevalence and Minimally Invasive Trends
The global vascular closure device market share is projected to grow from USD 1.73 billion in 2022 to USD 3.03 billion by 2030, driven by the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures. Innovations in device technologies, such as collagen-based and mechanical devices, are boosting market growth. North America leads the market, while Asia Pacific is expected to register the highest growth during the forecast period. US & Canada, April 03, 2025 (GLOBE NEWSWIRE) -- US & Canada, Apr, 01, 2025 (GlobeNewswire) -- According to a comprehensive report from The Insight Partners, 'Vascular Closure Device Market Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report', The vascular closure device market size is projected to reach US$ 3.03 billion by 2030 from US$ 1.73 billion in 2022. The market is expected to register a CAGR of 7.1% in 2022–2030To explore the valuable insights in the Vascular Closure Devices Market report, you can easily download a sample PDF of the report- The global vascular closure devices market is growing significantly with the increasing prevalence of cardiovascular diseases. The vascular closure devices market is segmented on the basis of product type, access, procedure, and end user. The report runs an in-depth analysis of market trends, key players, and future opportunities. Competitive Strategy and Development Key Players: A few of the major companies operating in the vascular closure devices market are Cordis Corp., Transluminal Technologies LLC, Vasorum Ltd, Haemonetics Corp., Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, ENDOCOR GmbH & CO KG, and Medtronic Plc. Trending Topics: Cardiovascular Devices, Catheterization, Interventional Cardiology, Peripheral Artery Disease (PAD), Hemostasis Devices, Endovascular Devices, Minimally Invasive Surgery (MIS), Etc. Global Headlines on Vascular Closure Devices Market Cordis Awarded Vascular Closure Devices Agreement with Premier, Inc. for MYNX CONTROL VENOUS Vascular Closure Device PATCH Clinical Study of PerQseal Vascular Closure System Reaches 100-Patient Milestone Vivasure Medical to Unveil US Pivotal Data for PerQseal Elite Vascular Closure System Vascular Closure Devices Market Overview of Report Findings 1. Market Growth: The global vascular closure device market is expected to reach US$ 2.80 billion in 2030 from US$ 3.03 billion in 2022. The market is estimated to grow at a CAGR of 7.1% from 2022 to 2030. The growth of the market is attributed to the increasing prevalence of cardiovascular diseases and burgeoning demand for minimally invasive devices. However, the risk of infection related to vascular closure devices hinders the market growth. 2. Increasing Prevalence of Cardiovascular Diseases: Cardiovascular diseases, including coronary artery disease, heart attack, stroke, and peripheral artery disease, are among the major causes of mortality worldwide. The burgeoning prevalence of these diseases has resulted in an upsurge in interventional procedures such as angioplasty, catheterization, and stenting, all of which necessarily require successful post-procedure vascular closure techniques. As per the World Health Organization (WHO) 2021, cardiovascular diseases cause nearly 17.9 million deaths each year, which is approximately 32% of the total deaths in the world. As per the CDC, in the US alone, 1 in 20 adults aged 20 or more have coronary artery disease (CAD), indicating a huge patient base that needs interventional interventions. With the growing rate of interventional cardiology procedures such as catheterizations and angioplasties, there is an increasing need for reliable vascular closure mechanisms. As per the report Cardiac Catheterization Risks and Complications, published in 2023, over 1,000,000 cardiac catheterization procedures are performed annually in the US. The procedures usually need closure devices to close the site of access and mitigate complications such as bleeding, hematomas, and infections. 3. Rising Preference for Minimally Invasive Procedures: The use of minimally invasive procedures has grown tremendously in recent decades, as patients are looking for interventions that carry less risk, have faster recovery times, and cause fewer scars. Minimally invasive procedures such as catheterization, coronary angioplasty, and stent placements have gained popularity. Vascular closure devices are important in maintaining the safety and efficacy of such interventions, as most of these interventions might need a proper closing of vascular access sites. a. Collagen-Based Devices: Collagen-based closure devices present a minimally invasive alternative to conventional products. They establish instant hemostasis with fewer complications, diminishing the requirement for manual compression. The technology finds great application in patients who undergo coronary interventions wherein swift recovery is a prime requirement. b. Mechanical and Suture-Based Devices: Technologies in mechanical and suture-based devices provide shorter closure times, reduced complications, and better patient outcomes. Such technologies are especially relevant in high-volume centers and interventional centers, where the need for efficient and safe vascular access closure is increasing. 4. Geographical Insights: In 2022, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific, respectively. Asia Pacific is expected to register the highest CAGR in the vascular closure devices market during the forecast period. Market Segmentation The vascular closure device market, by product type, is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during 2022–2030. Based on access, the vascular closure device market has been segmented into femoral access and radial access. The femoral access segment held a larger share of the market in 2022, and radial access is expected to register a higher CAGR in the market during 2022–2030. Based on procedure, the vascular closure device market is segmented into interventional radiology, interventional cardiology, and endovascular surgeries. The interventional cardiology segment held the largest share of the market in 2022. The same segment is expected to register the highest CAGR in the market during 2022–2030. The vascular closure device market, by end user, is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment held the largest share of the market in 2022. However, the ambulatory surgical centers segment is expected to register the highest CAGR in the market during 2022–2030. The vascular closure devices market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. Conclusion The vascular closure devices market is expected to witness rapid growth owing to the rising incidence of cardiovascular diseases, surging demand for interventional treatments involving efficient closure methods, and increasing adoption of minimally invasive procedures. As healthcare practitioners and patients value the benefits of quicker recovery times, lower complication rates, and enhanced safety procedures, the adoption of cutting-edge vascular closure devices would continue to rise in the coming years as well. The vascular closure devices market is expected to grow further with continuous innovations and a strong new technology pipeline to address the changing requirements of the healthcare sector. The report from The Insight Partners lists several stakeholders—including manufacturers, healthcare providers, distributors and suppliers, and regulatory bodies—along with valuable insights on how to successfully navigate this evolving market landscape and unlock new opportunities. Related Reports- Cardiovascular Devices Market Key Players and Opportunities by 2031 Minimally Invasive Surgery Market Outlook, Dynamics and Strategic Insights by 2031 Interventional Cardiology Devices Market Share, Size, Trends, and Forecast by 2031 Endovascular Treatment Devices Market Overview, Growth, and Trends (2021-2031)About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Défense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit MathurE-mail: +1-646-491-9876 Press Release- in to access your portfolio
